ranibizumab 🐶 Veterinary Use | Indications/Contra | FAERs-F | FAERs-M | Orange Bk | BioActivity |

Stem definitionDrug idCAS RN
humanized origin 4971 347396-82-1

Description:

MoleculeDescription

Synonyms:

  • ranibizumab-nuna
  • byooviz
  • ranibizumab
  • lucentis
  • ranibizimumab
  • ranibizumab (genetical recombination)
A recombinant humanized monoclonal antibody fragment that binds VEGF-A to prevent its binding to VEGFR-1 and VEGFR-2 receptors. This activity reduces vessel permeability and angiogenesis in the treatment of neovascular age-related MACULAR DEGENERATION.
  • Molecular weight:
  • Formula:
  • CLOGP:
  • LIPINSKI: None
  • HAC: None
  • HDO: None
  • TPSA:
  • ALOGS:
  • ROTB: None

Drug dosage:

None

ADMET properties:

None

Approvals:

DateAgencyCompanyOrphan
Jan. 22, 2007 EMA Novartis Europharm Limited
June 30, 2006 FDA GENENTECH
Jan. 21, 2009 PMDA Novartis Pharma

FDA Adverse Event Reporting System (Female)

MedDRA adverse event termLikelihood ratioLikelihood ratio thresholdPatients taking drug having adverse eventPatients taking drug not having adverse eventPatients not taking drug having adverse eventPatients not taking drug not having adverse event
Visual acuity reduced 2833.52 25.15 724 15221 21102 63451975
Endophthalmitis 1249.73 25.15 266 15679 3326 63469751
Death 1206.42 25.15 882 15063 373499 63099578
Retinal haemorrhage 884.44 25.15 213 15732 4756 63468321
Cerebrovascular accident 779.29 25.15 426 15519 107598 63365479
Blindness 736.94 25.15 256 15689 21443 63451634
Retinal pigment epithelial tear 708.09 25.15 110 15835 149 63472928
Detachment of retinal pigment epithelium 675.47 25.15 112 15833 284 63472793
Eye haemorrhage 634.81 25.15 183 15762 8313 63464764
Vitreous floaters 570.95 25.15 156 15789 5810 63467267
Retinal oedema 553.79 25.15 103 15842 598 63472479
Visual impairment 550.73 25.15 312 15633 84134 63388943
Macular oedema 527.41 25.15 134 15811 3743 63469334
Eye pain 489.36 25.15 215 15730 33639 63439438
Vitreous haemorrhage 486.35 25.15 111 15834 1939 63471138
Age-related macular degeneration 419.64 25.15 82 15863 641 63472436
Subretinal fluid 404.18 25.15 74 15871 388 63472689
Photopsia 354.01 25.15 101 15844 4408 63468669
Metamorphopsia 352.72 25.15 77 15868 1086 63471991
Eye discharge 341.37 25.15 105 15840 5958 63467119
Eye pruritus 300.44 25.15 128 15817 18543 63454534
Choroidal neovascularisation 278.42 25.15 51 15894 268 63472809
Vision blurred 277.84 25.15 210 15735 91714 63381363
Intraocular pressure increased 266.49 25.15 87 15858 5991 63467086
Polypoidal choroidal vasculopathy 236.54 25.15 36 15909 38 63473039
Retinal exudates 226.03 25.15 49 15896 667 63472410
Eye irritation 222.04 25.15 109 15836 21862 63451215
Transient ischaemic attack 220.30 25.15 130 15815 37623 63435454
Retinal detachment 220.12 25.15 75 15870 5894 63467183
Retinal thickening 215.16 25.15 31 15914 13 63473064
Myocardial infarction 214.55 25.15 187 15758 99706 63373371
Cystoid macular oedema 211.97 25.15 54 15891 1521 63471556
Macular hole 207.60 25.15 47 15898 789 63472288
Vitritis 194.36 25.15 46 15899 946 63472131
Eye inflammation 189.56 25.15 66 15879 5533 63467544
Dry throat 181.04 25.15 67 15878 6698 63466379
Vitreous detachment 179.95 25.15 50 15895 1977 63471100
Subretinal fibrosis 165.90 25.15 27 15918 58 63473019
Macular fibrosis 165.02 25.15 34 15911 356 63472721
Non-infectious endophthalmitis 164.51 25.15 30 15915 153 63472924
Retinal vein occlusion 163.68 25.15 47 15898 2096 63470981
Retinal scar 157.17 25.15 28 15917 122 63472955
Retinal depigmentation 156.45 25.15 31 15914 262 63472815
Blindness unilateral 153.11 25.15 58 15887 6183 63466894
Ocular hyperaemia 153 25.15 89 15856 25055 63448022
Retinal disorder 146.87 25.15 41 15904 1649 63471428
Pharyngeal oedema 141.37 25.15 69 15876 13652 63459425
Cataract nuclear 140.80 25.15 35 15910 890 63472187
Cerebral infarction 138.60 25.15 82 15863 23811 63449266
Retinal neovascularisation 133.27 25.15 21 15924 33 63473044
Anterior chamber cell 131.92 25.15 30 15915 514 63472563
Macular degeneration 129.34 25.15 79 15866 24297 63448780
Cataract 126.78 25.15 109 15836 56944 63416133
Retinal cyst 126.66 25.15 21 15924 53 63473024
Retinal degeneration 122.19 25.15 31 15914 858 63472219
Vitreous opacities 118.06 25.15 25 15920 302 63472775
Uveitis 117.08 25.15 59 15886 12494 63460583
Iridocyclitis 114.18 25.15 37 15908 2485 63470592
Retinal artery occlusion 111.84 25.15 33 15912 1620 63471457
Macular scar 110.33 25.15 20 15925 98 63472979
Ocular hypertension 107.60 25.15 29 15916 1021 63472056
Visual field defect 105.53 25.15 45 15900 6516 63466561
Retinal ischaemia 104.76 25.15 23 15922 333 63472744
Vitreous disorder 93.33 25.15 17 15928 86 63472991
Retinal tear 92.68 25.15 27 15918 1267 63471810
Throat tightness 86.61 25.15 62 15883 24825 63448252
Retinal vascular disorder 81.99 25.15 17 15928 184 63472893
Disease progression 81.09 25.15 125 15820 122633 63350444
Diarrhoea 80.19 25.15 40 15905 715326 62757751
Fatigue 79.93 25.15 64 15881 887964 62585113
Retinal aneurysm 75.42 25.15 16 15929 195 63472882
Dry age-related macular degeneration 74.19 25.15 16 15929 212 63472865
Macular pigmentation 70.73 25.15 11 15934 15 63473062
Lacrimation increased 68.59 25.15 50 15895 20581 63452496
Cutis laxa 67.82 25.15 14 15931 148 63472929
Foreign body sensation in eyes 66.72 25.15 24 15921 2210 63470867
Rash 66.42 25.15 29 15916 560842 62912235
Alopecia 65.82 25.15 5 15940 337531 63135546
Glaucoma 63.26 25.15 46 15899 18859 63454218
Foreign body in eye 62.93 25.15 13 15932 138 63472939
Neovascular age-related macular degeneration 62.75 25.15 14 15931 219 63472858
Eye oedema 59.57 25.15 20 15925 1500 63471577
Ophthalmological examination abnormal 58.66 25.15 11 15934 67 63473010
Ischaemic stroke 58.52 25.15 43 15902 17914 63455163
Eye infection 55.94 25.15 36 15909 12109 63460968
Hypopyon 55.65 25.15 16 15929 716 63472361
Ocular discomfort 55.02 25.15 25 15920 4208 63468869
Choroidal haemorrhage 54.83 25.15 10 15935 51 63473026
Diabetic retinopathy 54.81 25.15 21 15924 2306 63470771
Posterior capsule opacification 54.69 25.15 11 15934 101 63472976
Drug intolerance 53.84 25.15 7 15938 308654 63164423
No adverse event 52.16 25.15 58 15887 41347 63431730
Maculopathy 51.80 25.15 20 15925 2242 63470835
Anterior chamber flare 51.64 25.15 10 15935 74 63473003
Blepharitis 51.60 25.15 21 15924 2704 63470373
Joint swelling 51.38 25.15 10 15935 327656 63145421
Pain 51.04 25.15 67 15878 740561 62732516
Eye disorder 49.65 25.15 43 15902 22642 63450435
Conjunctival haemorrhage 49.22 25.15 22 15923 3565 63469512
Conjunctival erosion 47.75 25.15 10 15935 114 63472963
Retinal fibrosis 46.70 25.15 7 15938 6 63473071
Rheumatoid arthritis 46.13 25.15 5 15940 253814 63219263
Tachyphylaxis 44.81 25.15 11 15934 265 63472812
Pyrexia 44.59 25.15 32 15913 470446 63002631
Retinoschisis 44.42 25.15 7 15938 11 63473066
Suspected transmission of an infectious agent via product 43.83 25.15 11 15934 291 63472786
Anterior chamber inflammation 42.96 25.15 11 15934 316 63472761
Arthralgia 42.94 25.15 48 15897 569662 62903415
Retinopathy proliferative 42.35 25.15 8 15937 51 63473026
Dysphonia 40.94 25.15 55 15890 47559 63425518
Visual acuity tests abnormal 40.87 25.15 8 15937 63 63473014
Exudative retinopathy 40.68 25.15 6 15939 4 63473073
Abdominal discomfort 40.51 25.15 15 15930 320870 63152207
Conjunctival bleb 40.40 25.15 7 15938 25 63473052
Disease recurrence 40.10 25.15 42 15903 27988 63445089
Arthropathy 39.34 25.15 6 15939 234786 63238291
Macular ischaemia 39.01 25.15 7 15938 32 63473045
Weight increased 38.73 25.15 9 15936 260783 63212294
Vitrectomy 38.64 25.15 9 15936 172 63472905
Treatment failure 38.62 25.15 3 15942 199040 63274037
Atrial fibrillation 38.20 25.15 88 15857 116548 63356529
Dry eye 38.01 25.15 49 15896 40712 63432365
Retinal drusen 37.15 25.15 6 15939 12 63473065
Vomiting 37.09 25.15 52 15893 559565 62913512
Vitreous adhesions 36.61 25.15 7 15938 48 63473029
Swelling 36.25 25.15 12 15933 275366 63197711
Photophobia 35.74 25.15 32 15913 17603 63455474
Staphylococcus test positive 35.41 25.15 18 15927 3878 63469199
Vitreous degeneration 35.18 25.15 6 15939 19 63473058
Hypotony of eye 34.59 25.15 8 15937 148 63472929
Peripheral swelling 34.29 25.15 12 15933 265930 63207147
Angina pectoris 34.26 25.15 40 15905 30038 63443039
Glare 34.17 25.15 7 15938 71 63473006
Corneal striae 34.10 25.15 5 15940 3 63473074
Myocardial ischaemia 33.58 25.15 27 15918 12832 63460245
Corneal oedema 33.48 25.15 13 15932 1480 63471597
Intraocular lens implant 32.93 25.15 9 15936 334 63472743
Product use issue 32.29 25.15 125 15820 220395 63252682
Macular detachment 32.17 25.15 7 15938 97 63472980
Hypertensive crisis 31.49 25.15 28 15917 15258 63457819
Sinusitis 31.40 25.15 9 15936 226644 63246433
Haemorrhagic stroke 31.29 25.15 19 15926 5773 63467304
Pruritus 31.17 25.15 27 15918 361426 63111651
Charles Bonnet syndrome 30.96 25.15 5 15940 10 63473067
Inappropriate schedule of product administration 30.32 25.15 75 15870 103890 63369187
Dyspnoea 30.15 25.15 77 15868 661236 62811841
Therapeutic product effect decreased 30.03 25.15 6 15939 193181 63279896
Choroidal effusion 30.01 25.15 9 15936 467 63472610
Iritis 29.82 25.15 15 15930 3160 63469917
Acute myocardial infarction 28.99 25.15 38 15907 32086 63440991
Drug interaction 28.41 25.15 11 15934 229120 63243957
Cataract subcapsular 27.99 25.15 9 15936 589 63472488
Abdominal pain 27.71 25.15 20 15925 293436 63179641
Retinal vasculitis 27.35 25.15 10 15935 964 63472113
Weight decreased 27.28 25.15 18 15927 276780 63196297
Posterior capsule rupture 26.92 25.15 4 15941 3 63473074
Infection 26.81 25.15 12 15933 229161 63243916
Choroidal detachment 26.64 25.15 7 15938 223 63472854
Macular cyst 26.59 25.15 5 15940 31 63473046
Decreased appetite 26.59 25.15 15 15930 251037 63222040
Retinal injury 26.23 25.15 7 15938 237 63472840
Completed suicide 26.12 25.15 3 15942 145670 63327407
Corneal opacity 26.07 25.15 9 15936 734 63472343
Conjunctival disorder 25.98 25.15 7 15938 246 63472831
Constipation 25.97 25.15 12 15933 224931 63248146
Corneal abrasion 25.96 25.15 10 15935 1114 63471963
Pain in extremity 25.95 25.15 27 15918 331459 63141618
Normal tension glaucoma 25.82 25.15 5 15940 37 63473040
Open angle glaucoma 25.43 25.15 7 15938 267 63472810
Cataract cortical 25.36 25.15 5 15940 41 63473036

FDA Adverse Event Reporting System (Male)

MedDRA adverse event termLikelihood ratioLikelihood ratio thresholdPatients taking drug having adverse eventPatients taking drug not having adverse eventPatients not taking drug having adverse eventPatients not taking drug not having adverse event
Visual acuity reduced 2836.57 30.67 739 12400 15410 34928382
Retinal haemorrhage 1186.43 30.67 293 12846 4796 34938996
Death 846.14 30.67 878 12261 397171 34546621
Macular oedema 844.07 30.67 200 12939 2714 34941078
Vitreous haemorrhage 788.09 30.67 182 12957 2191 34941601
Endophthalmitis 634.20 30.67 165 12974 3343 34940449
Detachment of retinal pigment epithelium 625.49 30.67 116 13023 404 34943388
Subretinal fluid 600.24 30.67 108 13031 302 34943490
Retinal pigment epithelial tear 598.82 30.67 102 13037 181 34943611
Retinal oedema 550.90 30.67 108 13031 540 34943252
Vitreous floaters 540.21 30.67 146 12993 3439 34940353
Cerebrovascular accident 407.21 30.67 300 12839 84511 34859281
Visual impairment 404.19 30.67 218 12921 35584 34908208
Choroidal neovascularisation 369.55 30.67 66 13073 174 34943618
Eye haemorrhage 322.66 30.67 102 13037 4203 34939589
Retinal detachment 319.88 30.67 107 13032 5284 34938508
Polypoidal choroidal vasculopathy 316.86 30.67 55 13084 115 34943677
Intraocular pressure increased 312.10 30.67 105 13034 5278 34938514
Vision blurred 279.17 30.67 188 12951 45775 34898017
Blindness 265.54 30.67 124 13015 14862 34928930
Eye pain 259.17 30.67 118 13021 13344 34930448
Retinal exudates 240.28 30.67 56 13083 700 34943092
Cerebral infarction 233.42 30.67 139 13000 27316 34916476
Myocardial infarction 228.17 30.67 253 12886 120832 34822960
Cystoid macular oedema 211.66 30.67 50 13089 665 34943127
Ocular hypertension 203.42 30.67 50 13089 794 34942998
Cataract 192.92 30.67 121 13018 26065 34917727
Retinal thickening 190.42 30.67 29 13110 11 34943781
Metamorphopsia 177.75 30.67 41 13098 488 34943304
Vitreous detachment 166.32 30.67 43 13096 845 34942947
Macular hole 159.08 30.67 32 13107 186 34943606
Blindness transient 155.45 30.67 50 13089 2176 34941616
Vitreous opacities 153.43 30.67 34 13105 333 34943459
Retinal disorder 148.05 30.67 40 13099 937 34942855
Diabetic retinopathy 144.22 30.67 45 13094 1772 34942020
Vitritis 142.19 30.67 38 13101 853 34942939
Increased insulin requirement 141.37 30.67 26 13113 85 34943707
Retinal vein occlusion 138.23 30.67 43 13096 1676 34942116
Ocular discomfort 137.10 30.67 45 13094 2089 34941703
Macular degeneration 128.07 30.67 43 13096 2143 34941649
Disease progression 121.90 30.67 175 12964 107902 34835890
Dry age-related macular degeneration 120.26 30.67 23 13116 98 34943694
Retinal tear 118.79 30.67 33 13106 860 34942932
Vitreous disorder 118.03 30.67 22 13117 79 34943713
Cataract nuclear 115.24 30.67 29 13110 509 34943283
Suture rupture 114.99 30.67 27 13112 349 34943443
Retinal ischaemia 114.21 30.67 27 13112 360 34943432
Retinal cyst 113.29 30.67 20 13119 48 34943744
Macular fibrosis 109.75 30.67 26 13113 350 34943442
Eye disorder 107.21 30.67 58 13081 9470 34934322
Glaucoma 106.51 30.67 52 13087 6860 34936932
Retinal degeneration 106.49 30.67 27 13112 489 34943303
Subretinal fibrosis 104.62 30.67 20 13119 85 34943707
Eye inflammation 100.44 30.67 36 13103 2182 34941610
Anterior chamber inflammation 100.07 30.67 23 13116 269 34943523
Ocular hyperaemia 99.88 30.67 59 13080 11393 34932399
Blindness unilateral 97.51 30.67 43 13096 4499 34939293
Neovascular age-related macular degeneration 96.65 30.67 21 13118 186 34943606
Retinal artery occlusion 94.51 30.67 33 13106 1852 34941940
Transient ischaemic attack 93.95 30.67 80 13059 27533 34916259
Retinal scar 92.87 30.67 22 13117 296 34943496
Macular scar 90.18 30.67 15 13124 21 34943771
Diarrhoea 89.36 30.67 19 13120 389893 34553899
Haemorrhage 87.34 30.67 102 13037 51268 34892524
Retinal neovascularisation 85.27 30.67 18 13121 137 34943655
Hypopyon 83.10 30.67 21 13118 375 34943417
Age-related macular degeneration 81.38 30.67 20 13119 317 34943475
Pyrexia 80.97 30.67 14 13125 332999 34610793
Visual field defect 79.03 30.67 37 13102 4446 34939346
Disease recurrence 78.75 30.67 65 13074 21425 34922367
Serous retinal detachment 78.58 30.67 22 13117 590 34943202
Retinal aneurysm 76.97 30.67 16 13123 112 34943680
Hyphaema 74.91 30.67 21 13118 566 34943226
Macular ischaemia 72.40 30.67 14 13125 64 34943728
Diabetic retinal oedema 70.26 30.67 16 13123 179 34943613
Neovascularisation 70.16 30.67 12 13127 22 34943770
Ocular vascular disorder 68.52 30.67 15 13124 138 34943654
Diabetic foot 68.37 30.67 29 13110 2759 34941033
Non-infectious endophthalmitis 67.86 30.67 15 13124 145 34943647
Retinal depigmentation 65.53 30.67 12 13127 38 34943754
Inappropriate schedule of product administration 64.49 30.67 97 13042 62199 34881593
Fatigue 63.71 30.67 30 13109 370623 34573169
Uveitis 63.55 30.67 38 13101 7497 34936295
Corneal oedema 61.44 30.67 22 13117 1329 34942463
Toxicity to various agents 59.76 30.67 4 13135 200358 34743434
Posterior capsule opacification 59.54 30.67 13 13126 118 34943674
No adverse event 59.40 30.67 57 13082 22870 34920922
Macular cyst 58.68 30.67 9 13130 4 34943788
Cutis laxa 57.72 30.67 12 13127 84 34943708
Subretinal haematoma 56.81 30.67 9 13130 7 34943785
Foreign body sensation in eyes 55.80 30.67 17 13122 617 34943175
Eye oedema 55.28 30.67 18 13121 814 34942978
Anterior chamber cell 55.16 30.67 15 13124 360 34943432
Retinal vascular disorder 54.80 30.67 13 13126 176 34943616
Aphonia 53.83 30.67 26 13113 3347 34940445
Photopsia 53.39 30.67 22 13117 1946 34941846
Retinal vasculitis 53.27 30.67 15 13124 411 34943381
Nausea 50.43 30.67 33 13106 339875 34603917
Maculopathy 49.11 30.67 17 13122 929 34942863
Acute kidney injury 48.89 30.67 27 13112 304961 34638831
Hypotension 48.25 30.67 12 13127 221637 34722155
Cataract traumatic 48.21 30.67 7 13132 0 34943792
Retinopathy proliferative 47.27 30.67 10 13129 77 34943715
Vitreous haze 46.75 30.67 9 13130 40 34943752
Corneal erosion 46.08 30.67 10 13129 88 34943704
Drug interaction 45.88 30.67 14 13125 225932 34717860
Poor peripheral circulation 44.84 30.67 18 13121 1489 34942303
Lacrimation increased 42.73 30.67 31 13108 8451 34935341
Eye irritation 41.23 30.67 29 13110 7532 34936260
Keratic precipitates 41.20 30.67 10 13129 150 34943642
Conjunctival haemorrhage 41.20 30.67 21 13118 3034 34940758
Visual acuity reduced transiently 39.91 30.67 9 13130 96 34943696
Hypotony of eye 39.33 30.67 9 13130 103 34943689
Pseudoendophthalmitis 39.27 30.67 8 13131 50 34943742
Ischaemic stroke 39.21 30.67 41 13098 18209 34925583
Myocardial ischaemia 39.01 30.67 40 13099 17368 34926424
Decreased appetite 38.20 30.67 8 13131 166384 34777408
Vitrectomy 37.27 30.67 9 13130 132 34943660
Thrombocytopenia 36.94 30.67 7 13132 156240 34787552
Device issue 36.69 30.67 30 13109 9747 34934045
Conjunctival bleb 36.57 30.67 7 13132 30 34943762
Ophthalmological examination abnormal 35.85 30.67 7 13132 34 34943758
Anaemia 35.44 30.67 22 13117 233313 34710479
Retinoschisis 34.73 30.67 6 13133 12 34943780
Corneal disorder 34.31 30.67 13 13126 921 34942871
Vitreous adhesions 34.10 30.67 6 13133 14 34943778
Visual acuity tests abnormal 33.93 30.67 7 13132 47 34943745
Conjunctival hyperaemia 33.82 30.67 17 13122 2385 34941407
Vomiting 32.83 30.67 27 13112 247594 34696198
Cataract subcapsular 31.98 30.67 10 13129 396 34943396
Tachyphylaxis 31.86 30.67 8 13131 139 34943653
Rash 31.15 30.67 23 13116 222729 34721063
Corneal abrasion 30.71 30.67 9 13130 285 34943507
Choroidal haemorrhage 30.68 30.67 7 13132 79 34943713

FDA Adverse Event Reporting System (Geriatric)

MedDRA adverse event termLikelihood ratioLikelihood ratio thresholdPatients taking drug having adverse eventPatients taking drug not having adverse eventPatients not taking drug having adverse eventPatients not taking drug not having adverse event
Visual acuity reduced 4216.26 23.80 1053 18724 28416 79696195
Endophthalmitis 1407.43 23.80 325 19452 6103 79718508
Retinal haemorrhage 1373.99 23.80 334 19443 7883 79716728
Macular oedema 1051.64 23.80 249 19528 5225 79719386
Detachment of retinal pigment epithelium 955.42 23.80 167 19610 649 79723962
Vitreous haemorrhage 921.37 23.80 208 19569 3505 79721106
Retinal pigment epithelial tear 887.09 23.80 145 19632 331 79724280
Death 859.34 23.80 864 18913 565650 79158961
Subretinal fluid 845.71 23.80 151 19626 681 79723930
Retinal oedema 752.76 23.80 140 19637 825 79723786
Choroidal neovascularisation 691.12 23.80 117 19660 357 79724254
Vitreous floaters 651.58 23.80 180 19597 7076 79717535
Eye haemorrhage 581.66 23.80 176 19601 9581 79715030
Cerebrovascular accident 566.27 23.80 395 19382 154897 79569714
Polypoidal choroidal vasculopathy 519.22 23.80 83 19694 154 79724457
Eye pain 514.71 23.80 229 19548 37349 79687262
Visual impairment 489.51 23.80 297 19480 91834 79632777
Age-related macular degeneration 455.16 23.80 92 19685 882 79723729
Retinal detachment 426.08 23.80 137 19640 9110 79715501
Intraocular pressure increased 414.42 23.80 134 19643 9071 79715540
Blindness 356.85 23.80 163 19614 28220 79696391
Retinal thickening 354.20 23.80 51 19726 22 79724589
Macular hole 350.85 23.80 72 19705 749 79723862
Cerebral infarction 343.82 23.80 185 19592 45491 79679120
Retinal exudates 338.00 23.80 75 19702 1160 79723451
Vision blurred 318.42 23.80 240 19537 105658 79618953
Photopsia 312.55 23.80 95 19682 5241 79719370
Metamorphopsia 254.31 23.80 60 19717 1233 79723378
Myocardial infarction 247.86 23.80 265 19512 183864 79540747
Cataract 237.47 23.80 163 19614 61957 79662654
Vitritis 229.89 23.80 59 19718 1735 79722876
Cystoid macular oedema 228.91 23.80 60 19717 1920 79722691
Macular fibrosis 226.15 23.80 49 19728 674 79723937
Transient ischaemic attack 224.73 23.80 148 19629 52547 79672064
Ocular hypertension 224.51 23.80 56 19721 1464 79723147
Macular degeneration 218.34 23.80 88 19689 11208 79713403
Disease progression 216.39 23.80 247 19530 184115 79540496
Retinal vein occlusion 215.47 23.80 64 19713 3259 79721352
Eye inflammation 211.89 23.80 74 19703 6339 79718272
Vitreous detachment 207.12 23.80 57 19720 2202 79722409
Retinal ischaemia 200.01 23.80 45 19732 743 79723868
Retinal disorder 198.59 23.80 54 19723 1993 79722618
Subretinal fibrosis 195.26 23.80 34 19743 128 79724483
Retinal tear 187.39 23.80 49 19728 1553 79723058
Diabetic retinopathy 184.88 23.80 56 19721 3050 79721561
Non-infectious endophthalmitis 183.12 23.80 36 19741 295 79724316
Retinal artery occlusion 181.64 23.80 56 19721 3238 79721373
Retinal degeneration 178.79 23.80 45 19732 1221 79723390
Retinal neovascularisation 178.11 23.80 32 19745 150 79724461
Retinal depigmentation 177.69 23.80 35 19742 290 79724321
Retinal cyst 177.28 23.80 30 19747 91 79724520
Vitreous opacities 173.79 23.80 39 19738 636 79723975
Dry throat 173.34 23.80 67 19710 7639 79716972
Ocular hyperaemia 173.21 23.80 100 19677 28106 79696505
Vitreous disorder 172.82 23.80 33 19744 228 79724383
Ocular discomfort 166.54 23.80 58 19719 4925 79719686
Dry age-related macular degeneration 156.62 23.80 31 19746 264 79724347
Blindness transient 153.52 23.80 54 19723 4722 79719889
Retinal scar 150.81 23.80 32 19745 396 79724215
Blindness unilateral 148.98 23.80 61 19716 8085 79716526
Anterior chamber cell 140.34 23.80 35 19742 914 79723697
Increased insulin requirement 138.62 23.80 26 19751 161 79724450
Eye discharge 137.63 23.80 53 19724 5981 79718630
Uveitis 137.33 23.80 72 19705 16758 79707853
Cataract nuclear 136.95 23.80 35 19742 1011 79723600
Visual field defect 129.72 23.80 57 19720 8988 79715623
Neovascular age-related macular degeneration 124.22 23.80 27 19750 377 79724234
Eye pruritus 123.81 23.80 72 19705 20498 79704113
Anterior chamber inflammation 120.05 23.80 28 19749 546 79724065
Pharyngeal oedema 119.78 23.80 65 19712 16207 79708404
Retinal vascular disorder 118.14 23.80 25 19752 305 79724306
Suture rupture 113.46 23.80 27 19750 576 79724035
Glaucoma 113.22 23.80 67 19710 19694 79704917
Macular scar 112.72 23.80 20 19757 86 79724525
Eye disorder 107.69 23.80 69 19708 23343 79701268
Diarrhoea 104.65 23.80 44 19733 880445 78844166
Hypopyon 100.93 23.80 28 19749 1114 79723497
Retinal aneurysm 99.18 23.80 21 19756 257 79724354
Haemorrhage 96.57 23.80 116 19661 91002 79633609
Iridocyclitis 93.36 23.80 35 19742 3669 79720942
Choroidal haemorrhage 90.55 23.80 18 19759 157 79724454
Serous retinal detachment 89.77 23.80 25 19752 1009 79723602
Toxicity to various agents 87.75 23.80 4 19773 421536 79303075
Macular ischaemia 86.46 23.80 16 19761 91 79724520
Eye oedema 84.60 23.80 28 19749 2035 79722576
Pyrexia 83.67 23.80 32 19745 678677 79045934
No adverse event 83.22 23.80 71 19706 37121 79687490
Throat tightness 83.14 23.80 63 19714 27844 79696767
Retinopathy proliferative 82.99 23.80 16 19761 117 79724494
Fatigue 80.22 23.80 68 19709 929659 78794952
Diabetic foot 79.62 23.80 31 19746 3601 79721010
Hyphaema 79.13 23.80 22 19755 882 79723729
Retinal vasculitis 78.83 23.80 24 19753 1329 79723282
Ischaemic stroke 77.73 23.80 65 19712 33066 79691545
Macular cyst 76.68 23.80 13 19764 40 79724571
Disease recurrence 74.70 23.80 72 19705 44037 79680574
Corneal oedema 74.30 23.80 27 19750 2593 79722018
Retinoschisis 72.05 23.80 12 19765 32 79724579
Foreign body sensation in eyes 71.66 23.80 25 19752 2132 79722479
Posterior capsule opacification 71.03 23.80 15 19762 181 79724430
Conjunctival bleb 69.10 23.80 13 19764 82 79724529
Eye irritation 69.04 23.80 50 19727 20631 79703980
Device issue 67.38 23.80 55 19722 27053 79697558
Visual acuity tests abnormal 65.85 23.80 13 19764 109 79724502
Subretinal haematoma 65.61 23.80 10 19767 11 79724600
Drug interaction 65.38 23.80 12 19765 415171 79309440
Lacrimation increased 65.32 23.80 50 19727 22427 79702184
Conjunctival haemorrhage 65.32 23.80 31 19746 5834 79718777
Rash 65.27 23.80 31 19746 578327 79146284
Cutis laxa 63.00 23.80 13 19764 139 79724472
Keratic precipitates 61.83 23.80 15 19762 348 79724263
Nausea 59.68 23.80 91 19686 957105 78767506
Tachyphylaxis 58.03 23.80 14 19763 317 79724294
Maculopathy 58.01 23.80 23 19754 2802 79721809
Exudative retinopathy 57.28 23.80 9 19768 14 79724597
Inappropriate schedule of product administration 56.47 23.80 111 19666 133517 79591094
Vomiting 54.54 23.80 51 19726 665777 79058834
Ophthalmological examination abnormal 53.58 23.80 10 19767 60 79724551
Joint swelling 53.39 23.80 5 19772 288641 79435970
Hypotony of eye 50.88 23.80 12 19765 246 79724365
Vitreous adhesions 50.48 23.80 9 19768 40 79724571
Abdominal pain 50.24 23.80 17 19760 389552 79335059
Vitreous haze 49.16 23.80 10 19767 99 79724512
Hypotension 49.02 23.80 24 19753 440293 79284318
Weight increased 48.26 23.80 6 19771 277380 79447231
Ocular vascular disorder 47.01 23.80 13 19764 511 79724100
Vitreous degeneration 46.85 23.80 8 19769 26 79724585
Decreased appetite 45.81 23.80 14 19763 342404 79382207
Staphylococcus test positive 45.23 23.80 25 19752 6456 79718155
Anterior chamber flare 45.03 23.80 10 19767 155 79724456
Visual acuity reduced transiently 44.95 23.80 11 19766 265 79724346
Aphonia 44.00 23.80 29 19748 10283 79714328
Retinal pallor 43.82 23.80 6 19771 0 79724611
Retinal pigment epitheliopathy 43.63 23.80 12 19765 462 79724149
Cataract subcapsular 43.27 23.80 14 19763 947 79723664
Pseudoendophthalmitis 43.01 23.80 8 19769 47 79724564
Drug intolerance 42.94 23.80 7 19770 264112 79460499
Alopecia 42.80 23.80 4 19773 231351 79493260
Pain 40.87 23.80 70 19707 703732 79020879
Iris neovascularisation 40.75 23.80 8 19769 65 79724546
Rheumatoid arthritis 40.22 23.80 3 19774 208467 79516144
Retinal injury 38.73 23.80 10 19767 301 79724310
Macular pigmentation 38.32 23.80 6 19771 9 79724602
Angina pectoris 37.93 23.80 55 19722 51677 79672934
Acute kidney injury 37.73 23.80 44 19733 519360 79205251
Posterior capsule rupture 37.57 23.80 6 19771 11 79724600
Diabetic retinal oedema 37.31 23.80 10 19767 349 79724262
Drug resistance 37.13 23.80 49 19728 42164 79682447
Retinal fibrosis 36.90 23.80 6 19771 13 79724598
Arthralgia 36.85 23.80 53 19724 571750 79152861
Macular detachment 36.73 23.80 9 19768 218 79724393
Retinal vascular occlusion 36.36 23.80 11 19766 596 79724015
Conjunctival retraction 36.02 23.80 6 19771 16 79724595
Dyspnoea 35.97 23.80 102 19675 856923 78867688
Iritis 35.80 23.80 18 19759 3837 79720774
Optical coherence tomography abnormal 35.76 23.80 6 19771 17 79724594
Eye infection 35.69 23.80 27 19750 11893 79712718
Dysphonia 35.37 23.80 56 19721 56816 79667795
Haemorrhagic stroke 35.26 23.80 26 19751 11020 79713591
Pruritus 34.96 23.80 28 19749 394620 79329991
Foreign body in eye 34.88 23.80 9 19768 270 79724341
Anaemia 34.18 23.80 36 19741 444979 79279632
Blepharitis 33.23 23.80 16 19761 3108 79721503
Retinal drusen 33.07 23.80 6 19771 30 79724581
Conjunctival erosion 33 23.80 8 19769 185 79724426
Suspected transmission of an infectious agent via product 32.80 23.80 12 19765 1174 79723437
Neovascularisation 32.23 23.80 12 19765 1233 79723378
Abdominal discomfort 32.19 23.80 11 19766 250716 79473895
Pain in extremity 32.11 23.80 26 19751 364512 79360099
Corneal disorder 31.43 23.80 14 19763 2277 79722334
Choroidal effusion 31.04 23.80 10 19767 667 79723944
Detachment of macular retinal pigment epithelium 30.70 23.80 5 19772 11 79724600
Open angle glaucoma 30.68 23.80 9 19768 438 79724173
Weight decreased 30.46 23.80 26 19751 355172 79369439
Thrombocytopenia 30.19 23.80 14 19763 265245 79459366
Acute myocardial infarction 30.14 23.80 62 19715 76974 79647637
Charles Bonnet syndrome 30.11 23.80 5 19772 13 79724598
Somnolence 29.80 23.80 11 19766 238970 79485641
Fundoscopy abnormal 29.53 23.80 6 19771 59 79724552
Eye injury 29.52 23.80 14 19763 2629 79721982
Concomitant disease aggravated 29.16 23.80 25 19752 13142 79711469
Giant cell arteritis 28.99 23.80 14 19763 2737 79721874
Conjunctival disorder 28.48 23.80 8 19769 333 79724278
COVID-19 28.43 23.80 3 19774 157671 79566940
Aneurysm 28.43 23.80 15 19762 3533 79721078
Dry eye 28.15 23.80 40 19737 36891 79687720
Chorioretinal scar 27.86 23.80 6 19771 80 79724531
Myocardial ischaemia 27.84 23.80 33 19744 25486 79699125
Pancytopenia 27.82 23.80 4 19773 165741 79558870
Constipation 27.77 23.80 18 19759 283032 79441579
IIIrd nerve paresis 27.77 23.80 7 19770 191 79724420
Choroidal detachment 27.56 23.80 9 19768 627 79723984
Abnormal sensation in eye 27.11 23.80 12 19765 1923 79722688
Intraocular lens implant 26.78 23.80 8 19769 415 79724196
Vitrectomy 26.64 23.80 7 19770 226 79724385
Stomatitis 25.94 23.80 3 19774 146754 79577857
Oedema peripheral 24.81 23.80 16 19761 252272 79472339
Sudden visual loss 24.72 23.80 5 19772 48 79724563
White blood cell count decreased 24.62 23.80 8 19769 188280 79536331
Asthenopia 24.52 23.80 12 19765 2415 79722196
Arthropathy 24.10 23.80 7 19770 177104 79547507
Aspartate aminotransferase increased 24.09 23.80 3 19774 138638 79585973
Anterior chamber disorder 24.08 23.80 6 19771 156 79724455
Peripheral swelling 24.02 23.80 19 19758 269598 79455013

FDA Adverse Event Reporting System (Pediatric)

None

Pharmacologic Action:

SourceCodeDescription
ATC S01LA04 SENSORY ORGANS
OPHTHALMOLOGICALS
OCULAR VASCULAR DISORDER AGENTS
Antineovascularisation agents
MeSH PA D020533 Angiogenesis Inhibitors
MeSH PA D000970 Antineoplastic Agents
MeSH PA D006131 Growth Inhibitors
MeSH PA D006133 Growth Substances
FDA MoA N0000193542 Vascular Endothelial Growth Factor Inhibitors
FDA EPC N0000193543 Vascular Endothelial Growth Factor Inhibitor

Drug Use | Suggest Off label Use Form| |View source of the data|

DiseaseRelationSNOMED_IDDOID
Diabetic retinopathy indication 4855003 DOID:8947
Choroidal retinal neovascularization indication 75971007
Central retinal vein occlusion with macular edema indication 232039004
Branch retinal vein occlusion with macular edema indication 232048009
Age related macular degeneration indication 267718000 DOID:10871
Macular edema due to diabetes mellitus indication 312912001 DOID:9191
Exudative age-related macular degeneration indication 414173003 DOID:10873
Retinopathy of prematurity indication 415297005 DOID:13025
Eye infection contraindication 128351009




🐶 Veterinary Drug Use

None

🐶 Veterinary products

None

Acid dissociation constants calculated using MoKa v3.0.0

None

Orange Book patent data (new drug applications)

None

Orange Book exclusivity data (new drug applications)

None

Bioactivity Summary:

TargetClassPharosUniProtActionTypeActivity value
(-log[M])
Mechanism
action
Bioact sourceMoA source
Vascular endothelial growth factor A Secreted ANTIBODY BINDING DRUG LABEL DRUG LABEL

External reference:

IDSource
D05697 KEGG_DRUG
4025260 VUID
N0000179788 NUI
4025260 VANDF
4041511 VANDF
CHEMBL1201825 ChEMBL_ID
C000719192 MESH_SUPPLEMENTAL_RECORD_UI
6779 IUPHAR_LIGAND_ID
DB01270 DRUGBANK_ID
2602351 RXNORM
21678 MMSL
350639 MMSL
39922 MMSL
83454 MMSL
011622 NDDF
018852 NDDF
422456007 SNOMEDCT_US
425256004 SNOMEDCT_US
D000069579 MESH_DESCRIPTOR_UI
C1566537 UMLSCUI
8313 INN_ID
ZL1R02VT79 UNII

Pharmaceutical products:

ProductCategoryIngredientsNDCFormQuantityRouteMarketingLabel
Susvimo HUMAN PRESCRIPTION DRUG LABEL 1 50242-078 INJECTION, SOLUTION 100 mg INTRAVITREAL BLA 30 sections
Susvimo HUMAN PRESCRIPTION DRUG LABEL 1 50242-078 INJECTION, SOLUTION 100 mg INTRAVITREAL BLA 30 sections
Susvimo HUMAN PRESCRIPTION DRUG LABEL 1 50242-078 INJECTION, SOLUTION 100 mg INTRAVITREAL BLA 30 sections
LUCENTIS HUMAN PRESCRIPTION DRUG LABEL 1 50242-080 INJECTION, SOLUTION 10 mg INTRAVITREAL BLA 28 sections
LUCENTIS HUMAN PRESCRIPTION DRUG LABEL 1 50242-080 INJECTION, SOLUTION 10 mg INTRAVITREAL BLA 28 sections
LUCENTIS HUMAN PRESCRIPTION DRUG LABEL 1 50242-082 INJECTION, SOLUTION 6 mg INTRAVITREAL BLA 28 sections
LUCENTIS HUMAN PRESCRIPTION DRUG LABEL 1 50242-082 INJECTION, SOLUTION 6 mg INTRAVITREAL BLA 28 sections
Byooviz nuna HUMAN PRESCRIPTION DRUG LABEL 1 64406-019 INJECTION, SOLUTION 10 mg INTRAVITREAL BLA 30 sections
Byooviz nuna HUMAN PRESCRIPTION DRUG LABEL 1 64406-019 INJECTION, SOLUTION 10 mg INTRAVITREAL BLA 30 sections
Byooviz nuna HUMAN PRESCRIPTION DRUG LABEL 1 64406-019 INJECTION, SOLUTION 10 mg INTRAVITREAL BLA 30 sections
CIMERLI HUMAN PRESCRIPTION DRUG LABEL 1 70114-440 INJECTION, SOLUTION 0.30 mg INTRAVITREAL BLA 30 sections
CIMERLI HUMAN PRESCRIPTION DRUG LABEL 1 70114-440 INJECTION, SOLUTION 0.30 mg INTRAVITREAL BLA 30 sections
CIMERLI HUMAN PRESCRIPTION DRUG LABEL 1 70114-441 INJECTION, SOLUTION 0.50 mg INTRAVITREAL BLA 30 sections
CIMERLI HUMAN PRESCRIPTION DRUG LABEL 1 70114-441 INJECTION, SOLUTION 0.50 mg INTRAVITREAL BLA 30 sections